First Marijuana Consumption Lounge in Nevada Set to Open by Month’s End

Earlier this month, the Nevada Cannabis Control Board announced that it had awarded its first marijuana consumption lounge license. This announcement comes after the board approved a handful of these licenses over the last couple months.

The first to receive a lounge license was Thrive Cannabis Marketplace. Mitch Britten, CEO and managing partner of Thrive, stated that the company was honored to be at the forefront of the marijuana industry in Nevada through the official launch of the first regulated marijuana lounge in the state.

Britten revealed that the company had created a unique destination for marijuana enthusiasts to enjoy an assorted range of premium products in an engaging atmosphere. The lounge, dubbed Smoke and Mirrors, will provide a curated selection of premium marijuana products, including infused beverages.

It is important to keep in mind that alcohol will not be offered on the premises in accordance with state law. The compliance board also issued a statement about the company, noting that it was the first lounge that was inspected by its agents and adhered to the stipulated regulations.

A conditional license was issued to Thrive in June of last year. The zoning commission from Clark County then issued the company a special use permit in September. The lounge was then inspected in February of this year, which enabled Thrive to obtain its operation license.

In addition, the Nevada Cannabis Control Board revealed that 19 lounges had received approval for conditional licenses thus far. Of this number, five are independently situated and 14 are attached to dispensaries. The first independently located consumption lounge to receive a license was LA Lounge LLC.

Thrive’s lounge will operate in what was once a strip club and may be launched by the end of February, if all goes well.

Tyler Klimas, former executive director of the cannabis control board, recently discussed marijuana consumption lounges on a Weed Wonks podcast. He talked about how this was an unknown space and noted that many businesses would be launched in the near future.

The other consumption lounge that received a conditional license, Planet 13, issued a statement on a possible date for its launch. Larry Scheffler, Planet 13 co-CEO, stated that the company’s objective was to create an extraordinary space for marijuana connoisseurs, novices, locals and tourists to enjoy marijuana while experiencing world-class entertainment. The Planet 13 lounge will have bong chandeliers, VIP booths and marijuana cocktails.

The third conditional license was granted to SoL Cannabis.

The launch of these consumption lounges is likely to be watched closely by cannabis companies such as TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) since their success is likely to be copied in other jurisdictions where legal sales of adult-use marijuana exist.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW – Medical Cannabis Could Be Legalized in Spain, But Not Everyone Is Thrilled

Spain is making strides toward legalizing marijuana for medical use, with the Health Ministry initiating the introduction of new legislation to sanction its therapeutic application across various conditions. Reports from the Spanish media indicate that the proposed law is currently undergoing a phase of consultation and discussion. Residents, professionals and experts are asked to contact the ministry via email during this period to express their views on the subject.

Recently, Spain health secretary Javier Padilla had talks with scientific societies and professional associations after holding conversations with the EU Observatory of Marijuana Consumption and Cultivation. Further consultations are planned with the Spanish OECM.

The ministry noted that the upcoming bill is a well-thought-out policy based on recent scientific findings. Additionally, it said that the effectiveness of marijuana as a therapy alternative will be regularly assessed, with an emphasis on patient safety and product quality.

The regulatory framework aims to remain adaptable, rapidly integrating new evidence on marijuana’s medical benefits as it emerges.

However, there are dissenting voices, particularly regarding the exclusion of cannabis buds and home cultivation, which many patients advocate for. Initial provisions suggest that authorized medical cannabis products will primarily comprise oils, prescribed solely by SNS-approved doctors rather than private entities. Furthermore, only hospital pharmacists will be able to dispense the medications, which will restrict accessibility in comparison to the widely available corner dispensaries.

Currently, eligible patients include those undergoing chemotherapy for managing symptoms such as refractory pain, seizures, vomiting and nausea. The list of qualifying conditions is expected to expand in the future, according to sources.

Spain’s move toward medical marijuana legalization aligns with similar efforts in other European nations, including Portugal and Norway. The decision also reflects the growing demand for medical marijuana, with Spain projecting a significant increase in production to meet patient needs.

The Health Ministry anticipates producing 36 tons of medical marijuana this year, which is a 12.5-ton increase from last year. The increase is in line with a significant upward trend in medical marijuana output in the nation that began in 2022.

Approximately 400 kilograms were produced in 2018, according to the AEMPS, with an estimated 600 kilograms produced in 2021. This amount, however, increased dramatically to six tons in 2022 and then further quadrupled to 24 tons in 2023. More than 80% of this amount was exported for use as medical marijuana, with less than 20% reserved for research.

The numbers indicate that Spain has surpassed Portugal, which is frequently regarded as the center of Europe’s medical marijuana export industry and is predicted to generate 32 tons this year.

The growing wave of cannabis law reform around the world could open many international markets for established cannabis companies such as Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) that have gained immense experience in the North American market where they currently operate.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW – Prohibitionist States See Nearly Double Search Traffic for Delta-8 THC as Legal States

A recent study on the online search behavior concerning delta-8 THC says that the cannabinoid seems to be substantially more common in states where cannabis is still prohibited, based on information obtained from Google Trends. According to an analysis by CBD Nationwide, delta-8 THC online searches were almost twice as common in states where recreational marijuana is still illegal. This indicates that there has been a notable movement toward other cannabinoids in reaction to marijuana prohibitions.

A contributing factor to the popularity of delta-8 in these states is its extensive availability, both online and in physical stores such as gas stations, smoke shops and convenience stores. The cannabinoid, which is usually derived from hemp or synthesized from different parts of the plant, is legal in the United States.

According to the company, the difference in interest in the substance between states with differing cannabis laws was statistically significant, and the results were unlikely to have been caused by random chance, as evidenced by the very low p-value.

Google searches for the cannabinoid have increased dramatically in recent years, the study noted, with an 850% spike in the year 2021 alone. According to a 2023 AMA study, states that prohibit cannabis use may unintentionally promote the use of delta-8 items, a trend likely aggravated by hemp being federally legalized under the Farm Bill 2018.

The CBD Nationwide study indicated that there is more interest in delta-9 THC in states where cannabis is illegal, albeit to a lesser extent. To validate the results, the analysis used statistical tests such as Tukey’s Honestly Significant Difference (HSD) tests and analysis of variance (ANOVA).

The study, however, did not delve into the specific context of these searches, leaving it unclear if individuals in states where cannabis is illegal were seeking cannabinoid products or simply researching related laws and scientific information. Legislators, activists and business interests all have different opinions about how to regulate newly discovered cannabinoids. Certain states have chosen to prohibit or limit the sale of the substances, while others support updated federal regulations that treat intoxication cannabinoids apart from CBD.

State cannabis authorities have asked Congress to take into account laws that cover a wider range of newly discovered cannabinoids rather than only CBD.

Congress is expected to discuss the issue during the upcoming Farm Bill negotiations, which have been delayed due to a short-term extension of the existing legislation.

The analysis of search traffic shows that ending prohibition and letting cannabis companies such as Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED) to operate within a regulated marketplace facilitates public health because residents will not be pushed to try alternatives sourced from gray- or black-market actors.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks — Marigold PR Announces Upcoming Radicle Femmes Event Focused on Women in Cannabis

Marigold PR, an award-winning public relations agency to the North American cannabis industry, announced that it is hosting the first-ever Radicle Femmes event. According to the announcement, Radicle Femmes is designed to be Canada’s largest networking event celebrating women in cannabis. The premiere event is slated for March 8, 2024, which is International Women’s Day; it will be held in Toronto in collaboration with several sponsors, including the Ontario Cannabis Store, the Panther Group, Sister Merci and Solei. The event is designed to highlight the achievements of women entrepreneurs, professionals and advocates in shaping the industry landscape. The agenda includes panel discussions and networking events that focus on topics ranging from challenges that women to face to access to funding and low representation in the space. The one-day event will include entrepreneurs, marketers, consultants, retail decision-makers, licensed producers, brand representatives and other ancillary services.

“Women are underrepresented in leadership positions in many industries, including the cannabis industry, despite their significant contribution to the sector,” said Ontario Cannabis Store vice president of corporate affairs, social responsibility and strategic engagement Tanya Watkins in the press release. “The OCS’s commitment to enabling a vibrant cannabis marketplace is tied to supporting a diverse and inclusive industry. We’re proud to sponsor Radicle Femmes, which celebrates the many contributions of women who continue pushing the legal cannabis industry forward.”

To view the full press release, visit https://cnw.fm/dEYjr

About Marigold PR

Marigold PR has become a leading force in elevating the profile of the cannabis industry through strategic communications and high-impact events. As an award-winning public relations agency, Marigold PR has established a portfolio that includes a diverse range of clients, from emerging startups to established industry leaders. Marigold PR has been instrumental in supporting and hosting high-profile cannabis events and conferences that serve as a nexus for like-minded businesses, thought leaders and influencers in the cannabis space. For more information about the company, visit www.MarigoldPR.com.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – MAISON BLOOM Announces New Owner-Partner as UFC Fighter, Entrepreneur Joins Company

MAISON BLOOM, creators of the world’s first all-natural elevated seltzer made from fully sustainable ingredients, has announced a new owner-partner. Marlon “Chito’ Vera, a well-known UFC fighter and entrepreneur, has joined the company, taking “a leap into the world of infused beverages and functional cannabinoid ready-to-drink beverages” as part of his mission to share his approach to “always-ready-living” with the world. Vera will serve as the company’s head of wellness. With Vera on board, MAISON BLOOM plans to launch the “Chito Challenge,” which will include a series of bold offerings and engagements that encourage people to live their best lives. According to the announcement, Vera lives by the mantra of “always being in fighting shape,” and he will be bringing that mentality to MAISON BLOOM, intent on changing the perception of infused beverages and joining the best in the craft-infused beverage category. “Chito is the epitome of an intentional purpose-driven athlete, and as soon as we got to talking, it was clear that he shares the same energy, drive and vision to sip into a life less ordinary,” said MAISON BLOOM CEO Nathan Johnson in the press release. “He’s got that B.C.E – Big Champion Energy – and we are so excited to bring his drive, energy and enthusiasm to the world of MAISON BLOOM’s infused beverages because it really is high time to drink different, eat cleaner, and live better.”

To view the full press release, visit https://cnw.fm/vwvpj

About MAISON BLOOM

MAISON BLOOM stands as the pioneer in the world’s first designer, full-spectrum, hemp-infused family of beverages. Emerging in 2020 during lockdown, MAISON BLOOM is dedicated to the clean food and beverage movement and stacking up awards year after year thanks to the company’s commitment to delivering premium infused Malternative(TM) Elevated Seltzers that offer a distinctive full-spectrum experience. MAISON BLOOM delivers on the promise of the freshness of homemade creations with fewer calories and low and natural sugars; MAISON BLOOM beverages are GMO free and additive free and are always ready to drink, thanks to the use of 100% pure, plant-based ingredients. For more information, visit the company website at www.LiveMaisonBloom.com.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW – Experts Say Marijuana Potency Has Dramatically Increased Over the Years

There has been a significant growth in both the THC potency and range of cannabis products in recent decades, according to recent research by the University of Mississippi’s School of Pharmacy. The study, conducted through the university’s Natural Center for Natural Products Research, involved testing marijuana samples seized in federal raids during the last 50 years. The findings reveal a significant increase in potency, with modern cannabis flower being 57%–67% stronger compared to those from the 1970s.

Since legalization in most states, such as Michigan, the cannabis market has undergone strict regulation and has expanded to provide users with even more potent products. Tyler Dutcher, who owns Barryton-based grow facility Vivid Farms, acknowledges the availability of highly potent products but also emphasizes the presence of lower dosage varieties to cater to different preferences.

Dutcher advises beginning with goods such as flower strains or infused edibles that have about 20% potency and progressively modifying the dosage according to personal tolerance. He notes that taking these products will give users greater control over their dosage.

Recent studies have investigated the link between cannabis use and psychosis, with The New York Times reporting on the risks associated with regular marijuana use, especially among teenagers and young adults. Another study published in the Missouri State Medical Association Journal in 2018 revealed that high-potency THC (greater than 15%) increased the psychosis risk threefold, with daily use leading to a fivefold increase in risk among individuals under the age of 18 years.

Timber Cannabis marketing representative Chivonne Rush notes that regulated dispensaries prioritize only adult cannabis use and are committed to educating consumers about the potential risks associated with marijuana use, particularly among youth. According to the Addiction Center, higher THC levels in marijuana products increase the likelihood of addiction and dependence. The organization noted that it is critical to find and carry out efficient treatment programs for people struggling with addiction disorders and that it is also critical to raise youth awareness of the risks and hazards that come with using these substances.

Dutcher advocates starting with smaller doses and being watchful for any unpleasant effects when it comes to intake, especially for nonregular users. He reassures that although some people may experience discomfort from consuming strong cannabis, major injury is unlikely and that education from trained staff at cannabis dispensaries is essential to encouraging appropriate consumption habits.

Given that marijuana industry actors have to compete with black-market products, the subject of the rising potency of cannabis products is more nuanced than one may initially think.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – Software Effective Solutions Corp. (SFWJ) to Expand Portfolio with Strategic Acquisition

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana), a leading holding company in the cannabis industry, today announced final stages of negotiations to acquire its sixth cannabis company in Colombia. The acquisition is extremely significant because of the company’s cannabis genetics license, which MedCana believes will revolutionize its potential to create and register unique cannabis genetic varieties for production and commercialization. “The addition of this new company to MedCana’s portfolio represents a significant leap forward in our commitment to innovation and excellence within the cannabis sector,” said Gabriel Diaz, CEO of MedCana. “By integrating this company’s cutting-edge genetics capabilities, MedCana will be poised to develop proprietary cannabis strains, enhancing the diversity and quality of our product offerings to meet the evolving needs of consumers and medical patients alike.”

To view the full press release, visit https://cnw.fm/NKN1E

About Software Effective Solutions Corp.

Software Effective Solutions/MedCana is a holding company focused on developing companies in the agricultural technology and cannabis industries. As MedCana moves forward with its expansion plans, the company remains committed to delivering on its promise of building a solid foundation for the future growth of its holdings. For more information, visit the company’s website at www.MedCana.net.

NOTE TO INVESTORS: The latest news and updates relating to SFWJ are available in the company’s newsroom at https://cnw.fm/SFWJ

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Navy Expands Cannabis Waiver as Recruitment Nosedives

The Navy is changing its policy for recruits who test positive for cannabis upon arriving at boot camp, choosing to grant waivers rather than dismiss them outright in light of the continuous difficulties the United States military faces in recruiting. Head of the Navy’s personnel policy and plans unit, Rear Admiral James Waters, explained that if a recruit tests positive for cannabis and admits to using it, an assessment is done to make sure there are no underlying problems.

The adaptation aims to align with social laws and provide an opportunity for young people to acclimate to the Navy’s culture during boot camp. This move is a reflection of larger military attempts to solve recruitment deficiencies and lower the boot-camp dropout rate, which is currently approximately 10%, marking one of the lowest in past years.

Waters stressed that with the Navy’s target of recruiting 40,000 sailors by the end of 2024, minimizing the loss of recruits during boot camp is crucial. However, he emphasized that the more permissive attitude is limited to THC testing and doesn’t extend to other substances.

The adjustment follows a similar move by the Air Force, which saw a significant increase in enlistment waivers granted to recruits testing positive for THC than initially anticipated. General Christopher Amrhein, the Air Force’s recruitment service commander, highlighted that the waiver policy helped mitigate the impact of missing the annual recruitment goal for the first time in more than two decades.

The unit reported that it had granted 165 waivers in the first year after they were made available. That is more than three times as many waivers as it had anticipated granting each year.

The Navy and the Air Force’s recent policies represent a departure from previous strict regulations related to marijuana use, particularly in the context of CBD and hemp products. Over the years, various military units have communicated specific rules to their members regarding marijuana use, emphasizing the prohibition of hemp, CBD and marijuana products, even in states where using those substances is legal.

The Navy, for instance, prohibited the use of CBD and hemp products in 2018, with subsequent updates explaining the rationale behind the rule change. Additionally, the Naval War College issued a notice in 2022 stating that marines and sailors could test positive for cannabis if they consumed Pepsi’s Rockstar drink, which contains hemp.

Meanwhile, an Air Force base in Massachusetts issued a warning in 2021 prohibiting military personnel from even bringing hemp-infused lip balms, shampoos and lotions onto the base.

Given the rate at which more people are taking to regulated products from licensed marijuana companies such as Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), the cannabis waivers offered by the different wings of the armed forces are a rightful response to the changing public perception of this substance.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Lexaria Bioscience Corp. (NASDAQ: LEXX) Doubles Down on GLP-1 Clinical Studies for 2024; Terms 2023 as its Most Successful and Active Year of R&D

  • Lexaria, a global innovator in drug delivery platforms to enhance bioavailability, announced recently that it will focus on GLP-1 applications for diabetes and weight loss for the 2024 calendar year
  • Chris Bunka, Lexaria’s CEO, has expressed his confidence in the company’s direction, reiterating the intention to demonstrate the superior performance of GLP-1 drugs processed with its patented DehydraTECH(TM) technology
  • The company looks to build on the success of the early-stage results achieved in 2023, and looks to embark on two human pilot studies, a multi-arm 12-week animal chronic study, a human chronic weight-loss and diabetes study, as well as a multi-month stability testing of DehydraTECH GLP-1

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced its 2024 R&D plans, with emphasis on GLP-1 investigations. GLP-1 agonists (glucagon-like peptide 1) is a class of drugs used for diabetes and weight loss.

This comes hot on the heels of a successful, active year of R&D in 2023, a year that saw significant strides in developing its patented DehydraTECH(TM) technology including its new foray into GLP-1 drugs. Chris Bunka, Lexaria’s CEO, expressed his confidence and overall optimism in the company’s new direction, reiterating the company’s intention to demonstrate the superior pharmacokinetics and safety/efficacy performance of GLP-1 drugs when formulated and processed with DehydraTECH (https://cnw.fm/5pVk5).

In 2023, DehydraTECH showed positive results in its 8-week study that involved 32 diabetic rodents. The study showed that DehydraTECH-CBD lowered triglyceride levels and body weight differential over the eight weeks, positive results that would also be replicated in its other studies including, but not limited to, hypertension, human hormones, and the overall reduced risk of oral nicotine. This laid the groundwork for Lexaria to explore a new class of molecules it had never worked on before, ultimately quietly launching its top-priority and unpublicized early-stage work program – GLP-1- for weight loss and diabetes control.

In the words of Mr. Bunka, this was a “high-risk program,” mainly because this class of drugs is considered “large molecules,” yet all of Lexaria’s previous investigations were concentrated on “small molecules.” However, by the end of November and early January 2024, the company reported positive interim and final human pilot study results using a single semaglutide dose of a Rybelsus(R) tablet to a matching dose from Rybelsus(R) that had been compound formulated in capsule form using DehydraTECH processing technology enhancements. This was a massive milestone for Lexaria, with Bunka describing the results as “surprising.” Of note was that DehydraTECH processing delivered a statistically-significant higher proportion of the semaglutide and did so more quickly, ultimately having a statistically-significant impact on blood sugar.

GLP-1 drugs have been receiving rising interest recently. Having received FDA approvals as recently as 2021 and 2022, mainly given its health benefits and potential market size, Lexaria understands that this could be the next best thing, hence its focus on this drug class.

“Our R&D plans for 2024 are very tightly focused and will be concentrated mainly on GLP-1 investigations,” noted Mr. Bunka.

“Given the overwhelming interest in the GLP-1 sector, this will be a main focus. We are not at this time planning additional 2024 research in the antiviral, nicotine, or PDE5 sectors. We have solid early-stage data in each of those areas that will allow us to build upon those at the right time,” he added.

Mr. Bunka has reiterated that 2024 will be the year that Lexaria’s hard work will prove its worth. He looks to follow up on the positive early-stage results achieved in 2023, even as it embarks on two human pilot studies, a multi-arm 12-week animal chronic study, a human chronic weight-loss and diabetes study, as well as a multi-month stability testing of DehydraTECH GLP-1. Mr. Bunka is confident that its focus on GLP-1 drugs will yield this outcome.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Operators Say Marijuana Incubators Could Boost Equity While Growing Business

A set of fresh marijuana incubators and mentorship initiatives now offer support and practical training to small-scale cannabis brands and newcomers, aiming to promote equity and create opportunities for individuals affected by the consequences of the drug war. In exchange, organizers anticipate gaining advantages from local community ties and affordable labor while also inspiring employees with purpose-driven tasks.

With the decline in available capital in the marijuana sector, most operators feel compelled to accomplish more with limited resources. Oscar Carrillo, who had served four years in prison for drug sales, found it discouraging that large multistate operators (MSOs) dominated the recreational cannabis industry in New Jersey when it first opened for business in 2022.

Carrillo eventually received a social-equity license, which he perceived as validation. However, he encountered new challenges. His venture, Magic Garden Botanicals, funded through his successful telecommunications enterprise, aimed for vertical integration. Yet, obtaining suitable real estate posed a significant obstacle.

Just when Carrillo’s intentions to purchase beachfront real estate in Penns Grove, New Jersey, failed, he met Cannabiz Incubator founder Alan Trzuskoski. Trzuskoski was seeking tenants from various segments of the marijuana supply chain for his new establishment in Bridgeton, New Jersey. Inspired by his experiences in the Silicon Valley tech industry, Trzuskoski currently operates Cannabiz Incubator as a landlord offering consulting services, intending to turn the operation into an accelerator model.

Recognizing real estate as a major obstacle for startups, Trzuskoski concentrated on obtaining property in Bridgeton, an area designated for impact, and obtained permission from the local government to house up to 15 companies at the Cannabiz Incubator location. He currently rents the space to 6 tenants. His ultimate goal is to create an ecosystem of more manageable, resource-constrained businesses that can take on the market leaders.Aspiring business owners and those who have previously engaged in the markets sometimes have close relationships with the community, which allows them to customize their services.

For example, Carrillo intends to take advantage of the popularity of outlet stores in New Jersey by providing low-cost cannabis items in nonbranded packaging in a dispensary designed to resemble one.

Elsewhere, Zenbarn Farms, based in Waterbury Center, Vermont, expanded its presence by acquiring various marijuana facilities from the departing Curaleaf Holdings, focusing on regenerative farming practices to align with local preferences. With funding from the Pennywise Foundation, the founders hope to grow their incubator program to offer extensive knowledge in the whole supply chain while highlighting reciprocal benefits through worker development programs. The new owners intend to use live soil and wildflowers planted around the greenhouse’s perimeter to broaden their regenerative farming practices to cater more to local interests as farmers.

Meanwhile, in Humboldt County, Cookies, a California marijuana brand that operates Cookies University, hosts five students every summer under strict social-equity criteria. The program, led by industry veterans such as Lindsey Renner, immerses students in all aspects of the supply chain during two months, providing an alternative to entrepreneurship for those more inclined towards employment in retail, manufacturing and cultivation.

After graduation, some students stay on to work with Cookies, while others land jobs at other cannabis companies. Others go back to their old markets or carry on with their activism in areas where marijuana is still illegal.

As more people access the kind of training that the likes of Cookies University offers, industry actors such as SNDL Inc. (NASDAQ: SNDL) could have a sizeable pool of well-trained job seekers to choose from.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN